1/196
Imma miss the color of 2nd and 3rd place medals cus we only getting 1st 😈
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Accuracy
Degree to which measurement is correct on avg. Smaller systematic error = higher accuracy. Not affected by sample size.
Acute conditions
Severe & sudden in onset.
Adjustment
Differences in populations being compared minimized via math. E.g. age-standardized rates.
Agent
Factor or form of energy whose presence, excessive presence, or relative absence is essential for occurrence of disease/adverse health (see chain of infection).
Infectivity
Ability to cause infection. [infected] / [exposed].
Pathogenicity
Ability to cause disease. [ill] / [infected].
Virulence
Ability to cause severe disease. [severely ill or dead] / [illness].
a
a
Anthroponosis
Disease that is spread from humans to animals.
Antibiotic
Microbial product that kills/inhibits growth of susceptible microorganisms.
Antibody
Proteins in blood produced in response to antigen.
Antigen
Substance (e.g. toxin or surface of microorganism) recognized as foreign that stimulates antibody production.
Antigenic Drift
Small changes in viruses' surface proteins over time. Produces new strains mostly unrecognized by immune system. Previously infected hosts retain some immunity to drifted strain.
Antigenic Shift
Multiple strains of virus combine. New subtype has mixture of surface antigens.
Antitoxin
Antibody to microbial toxin. Binds w/ and neutralizes toxin.
Attribute
Risk factor intrinsic to individual person, plant, etc.
Biological Marker
Traceable substance introduced into organism to examine organ function/health.
a
a
Body Burden
Total amount/concentration of substance in body.
Breakthrough Infection
Case of illness where a vaccinated individual becomes infected by a pathogen.
Broad-Spectrum Drug
Chemotherapeutic agent effective across wide range of pathogens.
Carrier
Harbors infectious agent.
a
Case Definition
Set of criteria for determining whether person should be identified as having a particular disease. Specifies clinical criteria (symptoms) and details of person, place, time.
Purpose
Defines cases for equal measurement across regions; unifies treatment for cases; identifies new outbreaks; gives future studies information; increases diagnosis accuracy.
Case (Case Report)
Detailed record of symptoms, signs, diagnosis, treatment, follow-up of individual patient. May contain patient demographic. Usually describes unusual/novel occurrence.
Census
Enumeration of population usually w/ details of residence, age, etc.
Chain of Infection
Infectious agent, reservoir/host, portal of exit, mode of transmission, portal of entry, infects susceptible host.
a
a
Chemotaxis
Move of organisms in response to a nutrient source/chemical gradient.
Chemotherapeutic Agent
Compound used in disease treatment that kills/inhibits growth of microorganisms at concentrations low enough to avoid damage to host.
Clinical Criteria
Medical features (E.g. symptoms, medical examination findings, laboratory results) used in a case definition.
Cohort
Well-defined group with common exposure.
Confidence Interval
Range of values likely to contain true population parameters.
Co-Interventions
Interventions other than treatment under study possibly applied differently for study & control groups.
Comorbidity
Presence of disease in patient other than studied disease.
Complement System
Group of circulating plasma proteins that plays major role in an animal's immune response.
Compliance
Extent to which patients follow medical advice.
Contact Tracing
Finds individuals w/ close contact w/ infected and monitors them for incubation period.
Contamination
Agent within host but has not invaded tissues.
Counterfactual Ideal
Exposed and unexposed cohorts have equal size.
a
a
Determinant
Underlying social, economic, cultural, environmental factors that affect health/disease changes.
a
a
a
Diagnosis
Determines disease and explains symptoms.
Dichotomous variable
Nominal variable with two mutually exclusive categories.
Disease
Harmful deviation from health.
Dose Commitment
Total dose equivalent that body, organ, or tissue would receive during specified period from radiological treatment.
Dose
Total amount of factor that reaches individual.
Infective Dose
Amount required to cause infection.
Dose-Response Relationship
Amount of exposure has direct relationship w/ severity/likelihood of health outcome. Typically s-shaped curve.
Effects (of Drugs)
Possible effects of _______
Additive: Response to multiple drugs equals sum of independent responses. Antagonistic: Response less than sum of independent responses. Synergistic: Response greater than sum of independent responses.
Effectiveness
Ability to produce results in field.
Efficacy
Ability to produce results under ideal conditions.
Efficiency
Ability to produce results w/ minimal resources.
Elimination
When incidence is zero (within area).
Emergence
Pathogen becomes present in new host species.
Emerging Disease
New in population, rapidly increasing in incidence or geographic range, or reappeared.
Environment
Domain where agents exist, survive, or originate or all that which is external to individual human host.
Antecedent
Spectrum of circumstances that set the stage for illness or outbreak.
Audit
Assessment of extent to which an organization observes practices that minimize harm to environment.
Epi-Curve
Histogram showing course of disease or outbreak to identify source of exposure. X-axis-units of time = 1/3-1/4 of incubation time. Y-axis-# of new cases.
Epidemic Investigation
This type of research determines causes & possible control measures for outbreaks of disease.
Epidemic Threshold
Point where disease in question becomes epidemic.
Equipoise
Ethical basis that presumes all treatment or control groups within clinical study are roughly equal or there is no significant prior knowledge that one will provide substantial benefit/harm.
Eradication
Termination of transmission of an agent.
Etiology
Study of cause of disease.
Etiologic Agents
Materials known or expected to contain pathogen.
Exclusion Criteria
Conditions that prevent entrance of candidates into an experiment.
Exposure
Contact or characteristic that puts at risk.
Acute: Up to fourteen days.
Intermediate: Over fourteen days and less than one year.
Chronic: Over a year.
Exposure Assessment
Estimates or measures magnitude, frequency, and duration of exposure to agent.
Extinction
Agent no longer exists in nature or lab.
FAT TOM
Food, acidity (Ph 4.6-7.5, thrive in 6.6-7.5), time (2-4 hrs), temp (41-135, thrive in 70-104 F), oxygen, moisture (activity .95-1). Conditions required for growth of foodborne pathogens.
Fomite
Inanimate object that transmits pathogen. Excludes: food, air, liquids.
Frequency Polygon
Graph of frequency distribution with values of variable on x-axis and number of observations on y-axis. Middle of top of bars are connected with a straight line.
Gold Standard
Procedure or measurement widely accepted as best available; ideally perfect sensitivity and specificity.
Gram Staining
Positive: Purple. Stain interacts w/ peptidoglycan layer (lacks outer membrane). Negative: Pink. Outer endotoxin membrane layer over peptidoglycan layer. Smoothness increases virulence and helps resist antibiotics.
HDI
Human development index. Ranks countries by combo of economic development, literacy, education, life expectancy, etc.
Healthcare Approaches
Clinical: Diagnosis, prevention, and treatment of illness in individuals. E.g. prescribing drugs. Public Health: Control and prevention of disease in populations or groups of individuals. E.g. handwashing awareness campaign.
Health Disparity
Preventable differences in disease burden due to low socioeconomic status.
a
a
a
a
Health Planning Cycle
Assessing burden, identifying causes, measuring effectiveness of existing interventions, determining efficiency, implementing interventions, monitoring activities, and measuring progress.
Homeopathy
System of alternative medicine. Developed 1776 by Samuel Hahnemann. States that cause symptoms in healthy people will cure similar symptoms in sick people.
Host
Person/organism that can be infected by agent.
Compromised
If you have lowered resistance to infection, your immune system is __________
aa
aa
Intermediate/Secondary
Hosts immature or nonreproductive forms.
Paratenic
Intermediate host required for parasite's life cycle but agent doesn't grow there.
Reservoir
Primary host that shows no symptoms. Agent grows there. Source of infection.
Susceptible
Can't effectively resist invasion. Incl. children under five, the elderly, immunocompromised.
Host Factor
Traits of individual that affect susceptibility. E.g. age, religion, marital status, nutrition, previous exposure, race, substance abuse history.
Hypothesis
Testable statement of relationship (between exposure and disease). Should be clear, testable/resolvable, state relationship, specific, consistent with known facts, supported by research or theory.
Alternative
H1: Association (between exposure and disease).
Null
H0: No association (between exposure and disease).
ID50
Median infective dose; infects 50% of experimental group. Measures pathogenicity.
Immunoassay
Measures presence/concentration of macromolecule in solution through antibody or immunoglobulin.
Impairment
Any loss/abnormality of psychological, physiological, or anatomical structure/function.
Immunity
State of protection against infectious disease. Conferred either through _______ response generated by _______ization, previous infection, or other non-________ological factors.
Acquired Immunity
Type of Immunity develops after exposure to antigen or antibodies transfer from one to another.